Paloma Partners’s Genelux GNLX Stock Holding History

Paloma Partners’s Portfolio GNLX Stock Details GNLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50,000	Closed	-$135K	–	123
2025 Q1	$135K	Buy	+50,000	New	+$188K	0.02%	116

Other funds holding GNLX

WDC

Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

PWM

Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Paloma Partners's GNLX Position: Q2 2025 in Review

Paloma Partners sold out of Genelux (GNLX) in Q2 2025, closing a stake of 50,000 shares — an estimated $135K sold.

Paloma Partners first reported a position in GNLX in Q1 2025 and held it in 1 quarter. The position peaked at $135K in Q1 2025. 61 funds tracked by Wall St. Rank hold GNLX as of Q2 2025.

Paloma Partners reported no remaining Genelux position as of Q2 2025 after selling out during the quarter.
Paloma Partners sold 50,000 Genelux shares in Q2 2025, an estimated $135K.
Paloma Partners first reported a position in Genelux in Q1 2025 and held it in 1 quarter.
Paloma Partners's Genelux position peaked at $135K in Q1 2025.
61 funds tracked by Wall St. Rank held Genelux as of Q2 2025.

Based on Paloma Partners's 13F filing for Q2 2025, filed 14 Aug 2025.